MedTrace Logo

The Effect of Smart Phone Application Supported Nursing Care Program

NCT05392140 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2022-05-26

No results posted yet for this study

Summary

Hypertension is an important public health problem in our country and in the world. For success in hypertension treatment, timely and accurate diagnosis of patients, effective implementation of lifestyle changes, timely initiation of drug therapy and effective drug compliance are emphasized. The rapid adoption of smartphone technology provides a promising platform for overcoming drug non-compliance by providing medication intake reminders, healthy lifestyle education. It is emphasized that the health belief model can be used in the self-management of the hypertension patient's health and in the regulation of services with smart phone applications. Based on these facts, this study was planned to examine the effect of the smart phone management system supported nursing care program given by the nurse to the primary hypertension patients registered in the Family Health Center on the patient's compliance with the treatment and the blood pressure staying within the target limits. The research was organized in an experimental design with pre-test post-test control group. The population of the research consists of primary hypertensive patients registered in Family Health Centers in Tosya district of Kastamonu province. It is planned to include a total of 102 people, 51 in the intervention and control groups, in the sample group.

Conditions

Interventions

BEHAVIORAL

Health belief model-based smartphone-assisted nursing care program application will be installed on the phones of the patients who will be in the intervention group.

Health belief model-based smartphone-assisted nursing care program application will be installed on the phones of the patients who will be in the intervention group.

BEHAVIORAL

Standart care

Standart care

Sponsors & Collaborators

  • Ege University

    collaborator OTHER

  • Kastamonu University

    lead OTHER

Principal Investigators

  • Zeynep ARABACI · Kastamonu University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2022-11-25
Completion
2022-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05392140 on ClinicalTrials.gov